YU165486A - Process for obtaining vaccine against aids - Google Patents

Process for obtaining vaccine against aids

Info

Publication number: YU165486A
Authority: YU; Yugoslavia
Prior art keywords: vaccine against; against aids; obtaining vaccine; obtaining; aids
Prior art date: 1985-09-25

Application number

YU01654/86A

Other versions

YU46753B (en

Inventor

S L Hu

A F Purchio

L Madisen

Original Assignee

Oncogen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-09-25

Filing date

1986-09-25

Publication date

1989-08-31

1986-09-25 Application filed by Oncogen filed Critical Oncogen

1989-08-31 Publication of YU165486A publication Critical patent/YU165486A/en

1994-05-10 Publication of YU46753B publication Critical patent/YU46753B/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

YU165486A 1985-09-25 1986-09-25 RECOMBINANT VIRUS YU46753B (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US77990985A	1985-09-25	1985-09-25
US84298486A	1986-03-27	1986-03-27
US90521786A	1986-09-09	1986-09-09

Publications (2)

Publication Number	Publication Date
YU165486A true YU165486A (en)	1989-08-31
YU46753B YU46753B (en)	1994-05-10

Family

ID=27419757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
YU165486A YU46753B (en)	1985-09-25	1986-09-25	RECOMBINANT VIRUS

Country Status (22)

Country	Link
CN (1)	CN1020752C (en)
AT (1)	ATA256786A (en)
CH (1)	CH676247A5 (en)
DE (1)	DE3690508T1 (en)
DK (1)	DK455486A (en)
ES (2)	ES2002490A6 (en)
FI (1)	FI863848A (en)
FR (1)	FR2587720A2 (en)
GB (1)	GB2181435B (en)
GR (1)	GR862412B (en)
HU (1)	HU205780B (en)
IE (1)	IE59314B1 (en)
IL (1)	IL80073A (en)
IT (1)	IT1195829B (en)
MY (1)	MY103182A (en)
NL (1)	NL8602422A (en)
NO (1)	NO863803L (en)
NZ (1)	NZ217645A (en)
PT (1)	PT83434B (en)
SE (4)	SE8604007L (en)
WO (1)	WO1987002038A1 (en)
YU (1)	YU46753B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1341384C (en) *	1985-04-08	2002-08-20	Susan Mitsue Watanabe	Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav
US4734362A (en) *	1986-02-03	1988-03-29	Cambridge Bioscience Corporation	Process for purifying recombinant proteins, and products thereof
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
US4983387A (en) *	1986-05-19	1991-01-08	Viral Technologies Inc.	HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
EP0260714B1 (en) *	1986-09-19	1994-06-29	Oncogen Limited Partnership	The use of activated t-lymphocytes for preparing a pharmaceutical composition for the treatment of AIDS
IL84154A0 (en) *	1986-10-16	1988-03-31	Microgenesys Inc	Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
EP0272858A3 (en) *	1986-12-15	1989-07-12	Repligen Corporation	Recombinant hiv envelope proteins produced in insect cells
EP0283327B1 (en) *	1987-01-16	1997-06-25	Institut Pasteur	Peptides with the immunological properties of HIV-2
FR2610632B1 (en) *	1987-02-11	1990-12-21	Pasteur Institut	CHARACTERISTIC PEPTIDES OF HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN OF THESE VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
US5681713A (en) *	1987-05-08	1997-10-28	Smithkline Beecham Corporation	Expression of heterologous proteins in Drosophila cells
GB8714802D0 (en) *	1987-06-24	1987-07-29	Proteus Biotech Ltd	Synthetic polypeptides
DE10399032I1 (en) *	1987-08-28	2004-01-29	Health Research Inc	Recombinant viruses.
FR2620030B1 (en) *	1987-09-07	1990-03-23	Transgene Sa	VECTOR FOR THE EXPRESSION OF PROTEINS OF HIV-2 VIRUS, A CAUSAL AGENT FOR AIDS, CELL CULTURE INFECTED OR TRANSFORMED THROUGH THIS VECTOR, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
IL89118A0 (en) *	1988-02-03	1989-08-15	Microgenesys Inc	Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
US5763160A (en) *	1988-02-12	1998-06-09	United Biomedical, Inc.	Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
ES2059823T3 (en) *	1988-05-06	1994-11-16	Ferropas Ag	METHODS AND SYSTEMS FOR PRODUCING HIV ANTIGENS.
US5043262A (en) *	1988-05-12	1991-08-27	Dana Farber Cancer Institute	Protein, sequences containing the VPU gene therefore, vectors, methods of preparation and use
AP129A (en) *	1988-06-03	1991-04-17	Smithkline Biologicals S A	Expression of retrovirus gag protein eukaryotic cells
US5631154A (en) *	1988-06-10	1997-05-20	Therion Biologics, Incorporated	Self assembled, defective, non-self-propagating lentivirus particles
WO1989012095A1 (en) *	1988-06-10	1989-12-14	Applied Biotechnology, Inc.	A method of evaluating recombinant vaccines against immunodeficiency virus
US5747324A (en) *	1988-06-10	1998-05-05	Therion Biologics Corporation	Self-assembled, defective, non-self-propagating lentivirus particles
US5614404A (en) *	1988-06-10	1997-03-25	Theriod Biologics, Incorporated	Self-assembled, defective, non-self-propagating lentivirus particles
US5665577A (en) *	1989-02-06	1997-09-09	Dana-Farber Cancer Institute	Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
ATE160377T1 (en) *	1989-04-18	1997-12-15	Applied Biotechnology Inc	GENERATION OF HYBRID GENES AND PROTEINS BY RECOMBINATION USING VIRUSES
EP1288304A3 (en) *	1989-06-01	2006-04-05	Applied Biotechnology, Inc.	Self-assembled, defective, non-self-propagating viral particles
GB8923123D0 (en) *	1989-10-13	1989-11-29	Connaught Lab	A vaccine for human immunodeficiency virus
US5981276A (en) *	1990-06-20	1999-11-09	Dana-Farber Cancer Institute	Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
US5840312A (en) *	1991-05-02	1998-11-24	Institut Pasteur	Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
FR2676068B1 (en) *	1991-05-02	1994-11-04	Pasteur Institut	IMMUNOGENIC RECOMBINANT STRAINS OF B. ANTHRACIS - IMMUNOGENIC COMPOSITIONS CONTAINING THEM.
DK0611397T3 (en) *	1991-11-08	2002-10-07	Upjohn Co	Vaccine against cat leukemia virus
DE4405810A1 (en)	1994-02-23	1995-08-24	Behringwerke Ag	Peptides derived from a retrovirus from the HIV group and their use
AU5259796A (en) *	1995-02-10	1996-08-27	Worcester Foundation For Biomedical Research, Inc.	Delivery of exogenous compounds
US6013506A (en) *	1995-06-05	2000-01-11	Wardley; Richard C.	Feline leukemia virus vaccines
EP0762212B1 (en) *	1995-09-06	2000-01-12	Schablonentechnik Kufstein Aktiengesellschaft	Process for making a printing screen
US5741492A (en) *	1996-01-23	1998-04-21	St. Jude Children's Research Hospital	Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US6723558B1 (en)	1996-01-23	2004-04-20	St. Jude Children's Research Hospital	Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI324518B (en)	2001-12-19	2010-05-11	Nektar Therapeutics	Pulmonary delivery of aminoglycosides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3485810T2 (en) *	1983-05-27	1992-12-10	Texas A & M University Syst	METHOD FOR PRODUCING A RECOMBINANT BACULOVIRUS EXPRESSION VECTOR.
US4662514A (en) *	1983-11-01	1987-05-05	Charleswater Products, Inc.	Electrically conductive polymeric tubes for static sensitive electronic devices
IL76082A (en) *	1984-08-22	1991-07-18	Us Health	Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US9328391B1 (en) *	1984-08-22	2016-05-03	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Cloning and expression of HIV-1 DNA
GB8501473D0 (en) *	1985-01-21	1985-02-20	Pasteur Institut	Cloned dna sequences
ES8705522A1 (en) *	1984-10-18	1987-05-01	Pasteur Institut	A PROCEDURE FOR THE PREPARATION OF PURIFIED DERIVATIVES OF A GLYCOPROTEIN.
CA1341423C (en) *	1984-10-31	2003-03-04	Paul A. Luciw	Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
DE3588134T2 (en) *	1984-12-24	1997-03-20	Genentech Inc	Fusion of AIDS-related polypeptides
US4774175A (en) *	1985-03-01	1988-09-27	Centocor, Inc.	Immunochemical methods for the detection of antibody against HTLV-III
DK171119B1 (en) *	1985-04-19	1996-06-17	Hoffmann La Roche	AIDS virus envelope protein, expression vector carrying the envelope protein, transformants transformed with the expression vector, method of producing the virus envelope protein, method of detecting AIDS antibodies, method of determining AIDS virus, vaccine against AIDS, antibodies against the virus envelope protein and use of it to prepare a vaccine and for testing
FR2586427B1 (en) *	1985-08-20	1988-12-09	Pasteur Institut	NUCLEOTIDE AND POLYPEPTIDE SEQUENCES FROM VISNA VIRUS AND THEIR APPLICATION TO DIAGNOSTIC TESTS AND THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS

1986
- 1986-09-22 NZ NZ217645A patent/NZ217645A/en unknown
- 1986-09-22 GR GR862412A patent/GR862412B/en unknown
- 1986-09-23 IE IE252586A patent/IE59314B1/en not_active IP Right Cessation
- 1986-09-23 SE SE8604007A patent/SE8604007L/en not_active Application Discontinuation
- 1986-09-24 ES ES8602123A patent/ES2002490A6/en not_active Expired
- 1986-09-24 DK DK455486A patent/DK455486A/en not_active Application Discontinuation
- 1986-09-24 CH CH3821/86A patent/CH676247A5/fr not_active IP Right Cessation
- 1986-09-24 NO NO863803A patent/NO863803L/en unknown
- 1986-09-24 FI FI863848A patent/FI863848A/en not_active IP Right Cessation
- 1986-09-24 IT IT67730/86A patent/IT1195829B/en active
- 1986-09-24 HU HU864072A patent/HU205780B/en not_active IP Right Cessation
- 1986-09-24 GB GB8622987A patent/GB2181435B/en not_active Expired - Fee Related
- 1986-09-25 CN CN86106632A patent/CN1020752C/en not_active Expired - Fee Related
- 1986-09-25 FR FR8613414A patent/FR2587720A2/en active Granted
- 1986-09-25 AT AT0256786A patent/ATA256786A/en unknown
- 1986-09-25 WO PCT/US1986/002002 patent/WO1987002038A1/en active Application Filing
- 1986-09-25 NL NL8602422A patent/NL8602422A/en not_active Application Discontinuation
- 1986-09-25 YU YU165486A patent/YU46753B/en unknown
- 1986-09-25 DE DE19863690508 patent/DE3690508T1/de not_active Withdrawn
- 1986-09-25 PT PT83434A patent/PT83434B/en not_active IP Right Cessation
- 1986-12-31 IL IL8007386A patent/IL80073A/en not_active IP Right Cessation
1987
- 1987-09-29 MY MYPI87002188A patent/MY103182A/en unknown
1988
- 1988-05-13 ES ES8801494A patent/ES2006941A6/en not_active Expired
1991
- 1991-10-14 SE SE9102976A patent/SE9102976L/en not_active Application Discontinuation
- 1991-10-14 SE SE9102974A patent/SE9102974L/en not_active Application Discontinuation
- 1991-10-14 SE SE9102975A patent/SE9102975L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
SE9102975D0 (en)	1991-10-14
FI863848A0 (en)	1986-09-24
FR2587720A2 (en)	1987-03-27
SE9102976L (en)	1993-04-15
SE9102974D0 (en)	1991-10-14
GB8622987D0 (en)	1986-10-29
GR862412B (en)	1987-01-23
IT1195829B (en)	1988-10-27
GB2181435B (en)	1990-01-10
SE8604007D0 (en)	1986-09-23
SE9102974L (en)	1993-04-15
DK455486D0 (en)	1986-09-24
NZ217645A (en)	1991-11-26
IL80073A0 (en)	1986-12-31
IL80073A (en)	1995-01-24
FI863848A (en)	1987-03-26
NL8602422A (en)	1987-04-16
ATA256786A (en)	1995-05-15
ES2002490A6 (en)	1988-08-16
IE862525L (en)	1987-03-25
NO863803D0 (en)	1986-09-24
GB2181435A (en)	1987-04-23
PT83434B (en)	1988-07-29
MY103182A (en)	1993-05-29
CN1020752C (en)	1993-05-19
PT83434A (en)	1986-10-01
SE9102975L (en)	1993-04-15
DK455486A (en)	1987-03-26
IT8667730A0 (en)	1986-09-24
HU205780B (en)	1992-06-29
SE9102976D0 (en)	1991-10-14
IE59314B1 (en)	1994-02-09
FR2587720B2 (en)	1995-02-10
SE8604007L (en)	1987-03-26
ES2006941A6 (en)	1989-05-16
YU46753B (en)	1994-05-10
NO863803L (en)	1987-03-26
HUT42133A (en)	1987-06-29
CN86106632A (en)	1987-05-13
DE3690508T1 (en)	1988-06-23
WO1987002038A1 (en)	1987-04-09
CH676247A5 (en)	1990-12-28

Publication	Publication Date	Title
YU165486A (en)	1989-08-31	Process for obtaining vaccine against aids
LTIP1794A (en)	1995-08-25	Method for the production of an aids virus vaccine
EP0215379A3 (en)	1988-08-31	Process for preparing polyvinylpyrrolidone
YU99386A (en)	1988-04-30	Process for obtaining new thienopyridones
EP0199997A3 (en)	1988-01-13	Process for preparing diaryl-pentaerythritol
YU44603B (en)	1990-10-31	Process for obtaining hynolone
YU18286A (en)	1989-12-31	Process for obtaining vaccine against malaria
IL83810A0 (en)	1988-02-29	Vaccines for mycobacteria
PT83293B (en)	1988-10-06	Process for preparing dihidropyridine-2-hydroxyamines useful asmedicaments
PT83154A (en)	1986-09-01	Process for preparing quinolizinesulphonamides
ZA863454B (en)	1986-12-30	Process for preparing benzothiazolesulphenamides
HUT42766A (en)	1987-08-28	Process for preparing n-sulfamyl-3-(2-guanidino-thiazolyl-4-methyl-thio)-propionamidine
YU143386A (en)	1988-10-31	Process for preparing quartzite
YU218086A (en)	1988-06-30	Process for preparing herbicidically effective imidazolynones
YU100886A (en)	1988-04-30	Process for obtaining 2-bromine-alpha-ergocriptine
HUT43022A (en)	1987-09-28	Process for preparing monochloro-pinacolone
PT82643A (en)	1986-06-01	Process for preparing substituted hexanydro arylquinolizines
YU118187A (en)	1988-04-30	Process for obtaining mercaptoacylproline
YU196986A (en)	1988-10-31	Process for preparing alive vaccine against mumps
GB8704647D0 (en)	1987-04-01	Vaccine
HUT43039A (en)	1987-09-28	Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
HUT42769A (en)	1987-08-28	Process for preparing pyridazodiazepines
HUT43107A (en)	1987-09-28	Process for producing vaccine against melanome
YU179288A (en)	1989-02-28	Process for obtaining anilynoforumates
HUT42753A (en)	1987-08-28	Process for preparing aryl-cyanamides